Trial intelligence / Profile preview

Nasal Dexmedetomidine for Pediatric Pre-Anesthesia Sedation

NCT06896721Phase 4Not yet recruiting

Sponsor
Fuzhou Hua
Start
Mar 2025
Primary completion
Mar 2026
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial in preoperative anxiety and Emergence agitation (EA) comparing Dexmedetomidine with Placebo (2 arms). Primary endpoints: Success rate of preoperative sedation, Incidence of emergence agitation and 1 more. Planned start Mar 2025; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

preoperative anxietyEmergence agitation (EA)

Beyond the preview

Go deeper on NCT06896721.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06896721.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call